Impact of obesity, overweight and underweight on life expectancy and lifetime medical expenditures: the Ohsaki Cohort Study

被引:37
|
作者
Nagai, Masato [1 ]
Kuriyama, Shinichi [1 ,2 ]
Kakizaki, Masako [1 ]
Ohmori-Matsuda, Kaori [1 ]
Sone, Toshimasa [1 ]
Hozawa, Atsushi [1 ,3 ]
Kawado, Miyuki [4 ]
Hashimoto, Shuji [4 ]
Tsuji, Ichiro [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 980, Japan
[2] Tohoku Univ, Grad Sch Med, Environm & Genome Res Ctr, Dept Mol Epidemiol, Sendai, Miyagi 980, Japan
[3] Yamagata Univ, Grad Sch Med Sci, Dept Publ Hlth, Yamagata 990, Japan
[4] Fujita Hlth Univ, Sch Med, Dept Hyg, Toyoake, Aichi 47011, Japan
来源
BMJ OPEN | 2012年 / 2卷 / 03期
基金
日本学术振兴会;
关键词
BODY-MASS INDEX; HEALTH-CARE COSTS; SELF-REPORTED WEIGHT; ALL-CAUSE MORTALITY; NATIONAL-HEALTH; US HEALTH; FOLLOW-UP; JAPANESE; MIDDLE; BMI;
D O I
10.1136/bmjopen-2012-000940
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: People who are obese have higher demands for medical care than those of the normal weight people. However, in view of their shorter life expectancy, it is unclear whether obese people have higher lifetime medical expenditure. We examined the association between body mass index, life expectancy and lifetime medical expenditure. Design: Prospective cohort study using individual data from the Ohsaki Cohort Study. Setting: Miyagi Prefecture, northeastern Japan. Participants: The 41 965 participants aged 40-79 years. Primary and secondary outcome measures: The life expectancy and lifetime medical expenditure aged from 40 years. Results: In spite of their shorter life expectancy, obese participants might require higher medical expenditure than normal weight participants. In men aged 40 years, multiadjusted life expectancy for those who were obese participants was 41.4 years (95% CI 38.28 to 44.70), which was 1.7 years non-significantly shorter than that for normal weight participants (p=0.3184). Multiadjusted lifetime medical expenditure for obese participants was 112 pound 858.9 (94 954.1-131 840.9), being 14.7% non-significantly higher than that for normal weight participants (p=0.1141). In women aged 40 years, multiadjusted life expectancy for those who were obese participants was 49.2 years (46.14-52.59), which was 3.1 years non-significantly shorter than for normal weight participants (p=0.0724), and multiadjusted lifetime medical expenditure was 137 pound 765.9 (123 672.9-152 970.2), being 21.6% significantly higher (p=0.0005). Conclusions: According to the point estimate, lifetime medical expenditure might appear to be higher for obese participants, despite their short life expectancy. With weight control, more people would enjoy their longevity with lower demands for medical care.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Impact of walking on life expectancy and lifetime medical expenditure: the Ohsaki Cohort Study
    Nagai, Masato
    Kuriyama, Shinichi
    Kakizaki, Masako
    Ohmori-Matsuda, Kaori
    Sone, Toshimasa
    Hozawa, Atsushi
    Kawado, Miyuki
    Hashimoto, Shuji
    Tsuji, Ichiro
    [J]. BMJ OPEN, 2011, 1 (02):
  • [2] The impact of overweight and obesity on pediatric medical expenditures
    Wright D.R.
    Prosser L.A.
    [J]. Applied Health Economics and Health Policy, 2014, 12 (2) : 139 - 150
  • [3] Impact of overweight, obesity and severe obesity on life expectancy of Australian adults
    Lung, Thomas
    Jan, Stephen
    Tan, Eng Joo
    Killedar, Anagha
    Hayes, Alison
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2019, 43 (04) : 782 - 789
  • [4] Impact of overweight, obesity and severe obesity on life expectancy of Australian adults
    Thomas Lung
    Stephen Jan
    Eng Joo Tan
    Anagha Killedar
    Alison Hayes
    [J]. International Journal of Obesity, 2019, 43 : 782 - 789
  • [5] Impact of overweight and obesity on life expectancy, quality-adjusted life years and lifetime costs in the adult population of Ghana
    Lartey, Stella
    Si, Lei
    Lung, Thomas
    Magnussen, Costan G.
    Boateng, Godfred O.
    Minicuci, Nadia
    Kowal, Paul
    Hayes, Alison
    de Graaff, Barbara
    Blizzard, Leigh
    Palmer, Andrew J.
    [J]. BMJ GLOBAL HEALTH, 2020, 5 (09):
  • [6] Lifetime risk, life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for psoriasis in Taiwan: a nationwide cohort followed from 2000 to 2017
    Chiu, Hsien-Yi
    Lan, Joung-Liang
    Chiu, Ying-Ming
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2023, 14
  • [7] Psychological health in preschool children with underweight, overweight or obesity: a regional cohort study
    Donkor, Hilde Mjell
    Toxe, Helene
    Hurum, Jorgen
    Bjerknes, Robert
    Eide, Geir Egil
    Juliusson, Petur
    Markestad, Trond
    [J]. BMJ PAEDIATRICS OPEN, 2021, 5 (01)
  • [8] Estimation of life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for schizophrenia in Taiwan
    Leng, Chhian Hui
    Chou, Ming Hui
    Lin, Sheng-Hsiang
    Yang, Yen Kuang
    Wang, Jung-Der
    [J]. SCHIZOPHRENIA RESEARCH, 2016, 171 (1-3) : 97 - 102
  • [9] IMPACT OF HEALTHY LIFESTYLE FACTORS ON LIFE EXPECTANCY AND LIFETIME HEALTHCARE COST: A NATIONWIDE COHORT STUDY
    Lo, Wei-Cheng
    Hu, Tsuey-Hwa
    Shih, Cheng-Yu
    Lin, Hsien-Ho
    Hwang, Jing-Shiang
    [J]. INNOVATION IN AGING, 2023, 7 : 1062 - 1063
  • [10] Impact of walking upon medical care expenditure in Japan: the Ohsaki Cohort Study
    Tsuji, I
    Takahashi, K
    Nishino, Y
    Ohkubo, T
    Kuriyama, S
    Watanabe, Y
    Anzai, Y
    Tsubono, Y
    Hisamichi, S
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2003, 32 (05) : 809 - 814